Davita St. Luke's Bethlehem is a medicare approved dialysis facility center in Bethlehem, Pennsylvania and it has 36 dialysis stations. It is located in Lehigh county at 1425 8th Avenue, Bethlehem, PA, 18018. You can reach out to the office of Davita St. Luke's Bethlehem at (484) 403-4304. This dialysis clinic is managed and/or owned by Davita. Davita St. Luke's Bethlehem has the following ownership type - Profit. It was first certified by medicare in September, 2013. The medicare id for this facility is 392817 and it accepts patients under medicare ESRD program.
| Name | Davita St. Luke's Bethlehem |
|---|---|
| Location | 1425 8th Avenue, Bethlehem, Pennsylvania |
| No. of Dialysis Stations | 36 |
| Medicare ID | 392817 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1425 8th Avenue, Bethlehem, Pennsylvania, 18018 | |
| (484) 403-4304 | |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
| NPI Number | 1457787715 |
| Organization Name | St Lukes Bethlehem Dialysis |
| Doing Business As | Etowah Dialysis Llc |
| Address | 1425 8th Ave Bethlehem, Pennsylvania, 18018 |
| Phone Number | (484) 526-4894 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 59% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 17% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 24% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 42% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 35% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 14% |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 58% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 23% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 19% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 59% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 11% | 12% |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 80% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 20% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 58% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 27% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 15% | 12% |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 71 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 24 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 152 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1331 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
| Adult patients getting regular peritoneal dialysis at the center | 16 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 128 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 95 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita St. Luke's Bethlehem with elevated calcium levels.
| Patients with hypercalcemia | 166 |
| Hypercalcemia patient months | 1461 |
| Patients with Serumphosphor | 177 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 32 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 15 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 132 |
| Patient months included in arterial venous fistula and catheter summaries | 1030 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 154 |
| Hospitalization Rate in facility | 213.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 310.8 |
| Hospitalization Rate: Lower Confidence Limit | 155.1 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita St. Luke's Bethlehem were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 25.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 34.4 |
| Readmission Rate: Lower Confidence Limit | 18.4 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita St. Luke's Bethlehem get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.56 (As Expected) |
| SIR: Upper Confidence Limit | 2.52 |
| SIR: Lower Confidence Limit | .91 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita St. Luke's Bethlehem's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 120 |
| Transfusion Rate in facility | 55.9 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 97.8 |
| Transfusion Rate: Lower Confidence Limit | 34.3 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita St. Luke's Bethlehem lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 634 |
| Mortality Rate in facility | 13.5 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 17.1 |
| Mortality Rate: Lower Confidence Limit | 10.4 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago
Fresenius Medical Care Bethlehem Location: 2014 City Line Road, Suite 102, Bethlehem, Pennsylvania, 18017 Phone: (610) 264-9660 |
Davita St. Luke's Bethlehem Location: 1425 8th Avenue, Bethlehem, Pennsylvania, 18018 Phone: (484) 403-4304 |
Bio-Medical Applications Of Pennsylvania, Inc Location: 1005 Harvard Avenue, Bethlehem, Pennsylvania, 18015 Phone: (610) 997-8350 |
News Archive
HHS Secretary Kathleen Sebelius, Assistant Secretary for Health Dr. Howard K. Koh, and Agency for Healthcare Research and Quality Director Dr. Carolyn Clancy will host a conference call and discuss new reports on health care quality and health care disparities faced by racial, ethnic or income groups.
"A laboratory that will research and monitor emerging infectious diseases (EIDs) such as yellow fever and dengue" was launched in Kenya last month "in an attempt to tackle growing vector-borne health threats in the region," SciDev.Net reports.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study.
› Verified 2 days ago